Corticosteroids for managing tuberculous meningitis

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 4, 2016, Pages

  Prasad, Kameshwar ^a   Singh, Mamta B ^a   Ryan, Hannah ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PREDNISOLONE; GLUCOCORTICOID; TUBERCULOSTATIC AGENT;

ADVERSE DRUG REACTION; COCHRANE LIBRARY; DEATH; EMBASE; HUMAN; MEDLINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TUBERCULOUS MENINGITIS; ADJUVANT CHEMOTHERAPY; ADULT; CHILD; INTENTION TO TREAT ANALYSIS; META ANALYSIS; MORTALITY; TUBERCULOSIS, MENINGEAL;

ADULT; ANTITUBERCULAR AGENTS; CHEMOTHERAPY, ADJUVANT; CHILD; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INTENTION TO TREAT ANALYSIS; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUBERCULOSIS, MENINGEAL;

EID: 84964626295     PISSN: 1469493X     EISSN: 13616137     Source Type: Journal    
DOI: 10.1002/14651858.CD002244.pub4     Document Type: Review

References (65)

1. Chotmongkol V, Jitpimolmard S, Thavornpitak Y. Corticosteroid in tuberculous meningitis. Journal of the Medical Association of Thailand 1996;79(2):83-90.
2. Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatric Infectious Disease Journal 1991;10(3):179-83.
3. Kumarvelu S, Prasad K, Khosla A, Behari M, Ahuja GK. Randomized controlled trial of dexamethasone in tuberculous meningitis. Tubercle and Lung Disease 1994;75(3):203-7.
4. Lardizabal DV, Roxas AA. Dexamethasone as adjunctive therapy in adult patients with probable TB meningitis stage II and stage III: An open randomised controlled trial. Philippines Journal of Neurology 1998;4:4-10.
5. Malhotra HS, Garg RK, Singh MK, Agarwal A, Verma R. Corticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with tuberculous meningitis. Annals of Tropical Medicine and Parasitology 2009;103(7):625-34.
6. O'Toole RD, Thornton GF, Mukherjee MK, Nath RL. Dexamethasone in tuberculous meningitis. Relationship of cerebrospinal fluid effects to therapeutic efficacy. Annals of Internal Medicine 1969;70(1):39-48.
7. Prasad K. A randomized controlled trial to study the effectiveness of dexamethasone as an adjunct to standard antituberculous treatment in patients with clinically presumed tuberculous meningitis: 10-year follow-up study (as supplied 7 June 2015). Data on file.
8. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics 1997;99(2):226-31.
9. Simmons CP, Thwaites GE, Quyen NT, Chau TT, Mai PP, Dung NT, et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. Journal of Immunology 2005;175(1):579-90.
10. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. New England Journal of Medicine 2004;351(17):1741-51.
11. Török ME, Nguyen DB, Tran TH, Nguyen TB, Thwaites GE, Hoang TQ, et al. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One 2011;6(12):e27821.
12. Donald PR, Schoeman JF. Tuberculous meningitis. New England Journal of Medicine 2004;351(17):1719-20.
13. Escobar JA, Belsey MA, Dueñas A, Medina P. Mortality from tuberculous meningitis reduced by steroid therapy. Pediatrics 1975;56(6):1050-5.
14. Frieman I, Geefhuysen J. Evaluation of intrathecal therapy with streptomycin and hydrocortisone in tuberculous meningitis. Journal of Pediatrics 1970;76(6):895-901.
15. Girgis NI, Farid Z, Hanna LS, Yassin MW, Wallace CK. The use of dexamethasone in preventing ocular complications in tuberculous meningitis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1983;77(5):658-9.
16. Heemskerk AD, Bang ND, Mai NT, Chau TT, Phu NH, Loc PP, Chau NV, Hien TT, Dung NH, Lan NT, Lan NH, Lan NN, Phong le T, Vien NN, Hien NQ, Yen NT, Ha DT, Day JN, Caws M, Merson L, Thinh TT, Wolbers M, Thwaites GE, Farrar JJ. Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis. New England Journal of Medicine 14th January 2016;374(2):124-134.
17. Hockaday JM, Smith HM. Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis. Tubercle 1966;47(1):75-91.
18. Kalita J, Misra UK. Effect of methyl prednisolone on sensory motor functions in tuberculous meningitis. Neurology India 2001;49(3):267-71.
19. Kapur S. Evaluation of treatment of tuberculous meningitis since the use of steroids as an adjuvant. Indian Pediatrics 1969;6(3):166-71.
20. Karak B, Garg RK. Corticosteroids in tuberculous meningitis. Indian Pediatrics 1998;35(2):193-4.
21. Lepper MH, Spies HW. The present status of the treatment of tuberculosis of the central nervous system. Annals of the New York Academy of Sciences 1963;106:106-23.
22. Marras TK. Dexamethasone for tuberculous meningitis. New England Journal of Medicine 2005;352(6):628-30.
23. Quagliarello V. Adjunctive steroids for tuberculous meningitis - more evidence, more questions. New England Journal of Medicine 2004;351(17):1792-4.
24. Seligman SJ. Dexamethasone for tuberculous meningitis. New England Journal of Medicine 2005;352(6):628-30.
25. Shah I, Meshram L. High dose versus low dose steroids in children with tuberculous meningitis. Journal of Clinical Neuroscience 2014;21(5):761-4.
26. Vagenakis AG, Kyriazopoulou V. Dexamethasone for tuberculous meningitis. New England Journal of Medicine 2005;352(6):628-30.
27. Volijavec BF, Corpe RF. The influence of corticosteroid hormones in the treatment of tuberculous meningitis in Negroes. American Review of Respiratory Disease 1960;81(4):539-45.
28. Wosz-Höckert O. Modern treatment and late prognosis of tuberculous meningitis. Acta Paediatrica 1963;52 Suppl 141:93-102.
29. Weiss W, Flippin HF. The changing incidence of and prognosis of tuberculous meningitis. American Journal of the Medical Sciences 1965;250:46-59.
30. Alarcón F, Escalante L, Pérez Y, Banda H, Chacón G, Dueñas G. Tuberculous meningitis. Short course of chemotherapy. Archives of Neurology 1990;47(12):1313-7.
31. Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, Ortega A, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. New England Journal of Medicine 1992;326(10):668-72.
32. Berger JR. Tuberculous meningitis. Current Opinion in Neurology 1994;7(3):191-200.
33. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. Journal of Infection 2009;59(3):167-87.
34. Centers for Disease Control and Prevention. Treatment of Tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR 2003;52(RR-11):1-77.
35. D'Arcy-Hart P, Rees RJ. Enhancing effect of cortisone on tuberculosis in the mouse. Lancet 1950;2(6630):391-5.
36. Feldman S, Behar AJ, Weber D. Experimental tuberculous meningitis in rabbits. 1. Results of treatment with antituberculous drugs separately and in combination with cortisone. A. M. A. Archives of Pathology 1958;65(3):343-54.
37. Geiman BJ, Smith AL. Dexamethasone and bacterial meningitis. A meta-analysis of randomized controlled trials. Western Journal of Medicine 1992;157(1):27-31.
38. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
39. Jacobs RF, Sunakorn P. Tuberculous meningitis in children: an evaluation of chemotherapeutic regimens. American Review of Respiratory Disease 1990;141 Suppl:A337.
40. Jacobs RF, Sunakorn P, Chotpitayasunonah T, Pope S, Kelleher K. Intensive short course chemotherapy for tuberculous meningitis. Pediatric Infectious Disease Journal 1992;11(3):194-8.
41. Jorge JH, Graciela C, Pablo AP, Luis SH. A life-threatening central nervous system-tuberculosis inflammatory reaction nonresponsive to corticosteroids and successfully controlled by infliximab in a young patient with a variant of juvenile idiopathic arthritis. Journal of Clinical Rheumatology 2012;18(4):189-91.
42. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
43. Lee HS, Lee Y, Lee SO, et al Choi SH, Kim YS, Woo JH, et al. Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis. Journal of Infection and Chemotherapy 2012;18(4):555-7.
44. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Green S, Higgins JPT (editors). The Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration.
45. Molton JS, Huggan PJ, Archuleta S. Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction. Medical Journal of Australia 2015;202(3):156-7.
46. Medical Research Council Report. Streptomycin treatment of tuberculous meningitis. Lancet 1948;1(6503):582-96.
47. Naing C, Mak JW, Maung M, Wong SF, Kassim AI. Meta-analysis: the association between HIV infection and extrapulmonary tuberculosis. Lung 2013;191(1):27-34.
48. National Institute for Health and Care Excellence (NICE). Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE clinical guidelines 117. Manchester: NICE, March 2011.
49. Parsons M. Tuberculous Meningitis: Tuberculomas and Spinal Tuberculosis - A Handbook for Clinicians (Oxford Medical Publications). 2nd Edition. Oxford: Oxford University Press, 1988:32-62.
50. Ramachandran P, Duraipandian M, Nagarajan M, Prabhakar R, Ramakrishnan CV, Tripathy SP. Three chemotherapy studies of tuberculous meningitis in children. Tubercle 1986;67(1):17-29.
51. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
52. Schoeman JF, Ravenscroft A, Hartzenberg HB. Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess. Child's Nervous System 2001;17(6):370-2.
53. Schoeman JF, Springer P, van Rensburg AJ, Swanevelder S, Hanekom WA, Haslett PA, et al. Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study. Journal of Child Neurology 2004;19(4):250-7.
54. Schoeman JF, Andronikou S, Stefan DC, Freeman N, van Toorn R. Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in four consecutive cases. Journal of Child Neurology 2010;25(7):822-8.
55. Working Group of the Clinical Practice Guideline on the Diagnosis, Treatment and Prevention of Tuberculosis. Centro Cochrane Iberoamericano (Iberoamerican Cochrane Centre), coordinator . Clinical Practice Guideline on the Diagnosis, Treatment and Prevention of Tuberculosis. Quality Plan for the Spanish National Healthcare System of the Spanish Ministry for Health, Social Policy and Equality; Agència d'Informació, Avaluació i Qualitat en Salut de Catalunya (AIAQS - Agency for Information, Evaluation, and Quality in Health of Catalonia). Ministry of Science and Innovation, Spain, 2010.
56. Tandon PN, Bhatia R, Bhargava S. Tuberculous meningitis. In: Harris AA editor(s). Handbook of Clinical Neurology. Vol. 8, Amsterdam: Elsevier Science Publishers, 1988:195-226.
57. Thwaites GE, Chau TT, Stepniewska K, Phu NH, Chuong LV, Sinh DX, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002;360(9342):1287-92.
58. Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurology 2013;12(10):999-1010.
59. Tobin DM, Vary JC Jr, Ray JP, Walsh GS, Dunstan SJ, Bang ND, et al. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 2010;140(5):717-30.
60. Tobin DM, Roca FJ, Oh SF, McFarland R, Vickery TW, Ray JP, et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 2012;148(3):434-46.
61. Török ME, Nguyen DB, Tran TH, Nguyen TB, Thwaites GE, Hoang TQ, et al. Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents. PLoS One 2011;6(12):e27821.
62. World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization, 2014.
63. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD002244]
64. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD002244.pub2]
65. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD002244.pub3]